As IL-1 and IL-18 are main inflammatory mediators processed by inflammasomes, it remains unclear how the host immune system integrates IL-1 and IL-18 signals during colitis and inflammation-associated colon cancer. This evidence concerns the gene IL18 and colonic neoplasm.